COPENHAGEN, Denmark, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today announced …
BURLINGTON, ONTARIO, CANADA, November 25, 2020 /EINPresswire.com/ -- RAPID DOSE THERAPEUTICS SIGNS DEFINITIVE AGREEMENT TO ENABLE COMMERCIAL PRODUCTION OF ULTRAPURE THC™ DISTILLATE USING RDT’S NOVEL CBD TO THC CONVERSION TECHNOLOGY Rapid Dose …
It’s time to level up, the drip meter has been achieved and Hugo has made a name for himself thanks to the executive mindset and boss perspective ATLANTA, GA, USA, November 25, 2020 /EINPresswire.com/ -- Watch "CEO Flow" by Frank Hugo on Hip …
With Cannabinoid Ingredients on the Rise, Hempathy Becomes an Early Market Entrant in China’s Next Big Beauty Trend LOS ANGELES, CALIFORNIA, U.S., November 25, 2020 /EINPresswire.com/ -- Future State Brands announces today its official consumer market …
VALCOURT, Quebec, Nov. 25, 2020 (GLOBE NEWSWIRE) -- BRP Inc. (TSX:DOO; NASDAQ:DOOO) will hold its third quarter FY2021 financial results conference call on Wednesday, November 25, 2020. José Boisjoli, President and Chief Executive Officer, and Sébastien …
WATERTOWN, Mass., Nov. 25, 2020 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new class of small-molecule drugs that selectively destroys disease-causing proteins through degradation, today …
CAMBRIDGE, Mass., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is scheduled to present at the Piper …
FREDERICTON, N.B., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Teledyne CARIS, a Teledyne Technologies [NYSE:TDY] company, is pleased to announce significant funding from Canada’s Ocean Supercluster award to develop software for remote operations survey processing. …
Simple, single-dose nasal spray offers greater ease and comfort of administration; positioning AdCOVID as a differentiated vaccine candidate for adults and children AdCOVID is capable of stimulating an additional and specialized type of immunity – local …
CAMBRIDGE, Mass., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Jeff Goater, chief …
CAMBRIDGE, Mass., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced the presentation of clinical data at …
NEW YORK, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and …
NEW YORK, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and …
BOSTON, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients …
SOUTH SAN FRANCISCO, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for …
Detailed Mapping and Sampling Program Completed Drill Targets Selected at Sandra Prospect 1,500m Self-Funded Drill Program Scheduled for Q1 2021 VANCOUVER, British Columbia, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Mirasol Resources Ltd. (TSX-V: MRZ) (OTCPK: …
NEW HAVEN, Conn., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in two upcoming …
Reported net revenue of $3.2 million, an increase of 219% as compared to Q2 2020 Executed Letter of Understanding with SQDC to sell its flagship Simply BareTM Organic super-premium flower in Québec Advanced cannabis 2.0 product innovation pipeline with …
TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX)(OTCQB: ENGMF)(FSE: 2AV), the largest gaming platform in North America, connecting with over 300 million gamers monthly worldwide, …
CRL does not cite need for additional clinical studies CRL focuses on drug CMC and device biocompatibility information Conference Call Scheduled for Today at 9:00a.m. ET RESEARCH TRIANGLE PARK, N.C., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, …
